Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Rapidly is the Whole Genome And Exome Sequencing Market Expected to Expand Between 2025 and 2034 Based on Current Trends?

The size of the total genome and exome sequencing market has seen rapid expansion in recent years. The market, which stood at a value of $2.02 billion in 2024, is projected to climb to a size of $2.53 billion in 2025 with a Compound Annual Growth Rate (CAGR) of around 24.8%. The impressive growth recorded in the historical period can be traced back to factors such as the reduction in sequencing costs, an increase in genetic disorders, clinical use cases, genomic data archives, and advancements in the field of bioinformatics.

It is projected that the market size for whole genome and exome sequencing will experience substantial expansion in the forthcoming years, reaching $6.14 billion in 2029, growing at a compound annual growth rate (CAGR) of 24.9%. This growth over the forecast span can be linked to factors like initiatives in population genomics, an increasing need for precision medicine, progress in single-cell sequencing, growth in the scope of non-invasive prenatal testing (NIPT), and its application in the research of rare diseases. Key trends predicted during the forecasted timeline include wider clinical adoption, accelerated progress in sequencing technologies, emergence of large-scale genomic studies, the incorporation of artificial intelligence (AI) and machine learning (ML), along with widened applications in the field of oncology.

Which Drivers Are Expected to Have the Greatest Impact on the Whole Genome And Exome Sequencing Market’s Growth?

The burgeoning interest in customized medical treatment is predicted to fuel the expansion of the whole genome and exome sequencing market going forward. Customized medicine refers to the medical care practice that customizes healthcare decisions and actions to the particularities of every patient, taking into account aspects like genetics, environment, and way of life. Whole genome and exome sequencing aids in customized medicine by providing an all-encompassing examination of a person’s genetic structure. This allows health care decisions and actions to be customized based on their distinct genetic, environmental, and lifestyle factors. For instance, the Personalized Medicine Coalition (PMC), a US-based entity that encourages the comprehension and adoption of personalized medicine, projected in October 2022 that in excess of 75,000 genetic testing products and 300 personalized medicines will grace the market in 2022. Moreover, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) gave the green light to 37 new molecular entities (NMEs) in 2022. Of the 35 therapeutic NMEs, nearly 34%, amounting to 12, fall under the personalized category. As a consequence, the growing demand for personalized medicine is acting as a catalyst for the growth of the whole genome and exome sequencing market.

Get Your Free Sample of the Global Whole Genome And Exome Sequencing Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp

Who Are the Dominant Players Pushing the Boundaries of the Whole Genome And Exome Sequencing Market?

Major companies operating in the whole genome and exome sequencing market report are:

• Siemens AG_x000D_

• Hoffmann-La Roche Ltd._x000D_

• Thermo Fisher Scientific Inc._x000D_

• Cytiva (Danaher Corporation)_x000D_

• Laboratory Corporation of America Holdings (Labcorp)_x000D_

What Current Trends in the Whole Genome And Exome Sequencing Market Should Industry Players Pay Attention To?

Leading companies in the whole genome and exome sequencing markets are shifting their efforts to create cutting-edge technological systems, like ultra-fast NGS (next-generation sequencing) analysis, to stand out in the market. This new technology allows the processing of next-generation sequencing (NGS) data at an unprecedented pace, drastically cutting down on the time needed for genomic data analysis. To demonstrate, in January 2023, QIAGEN Digital Insights (QDI), a bioinformatics firm in the US, unveiled their ultra-fast NGS analysis platform. This platform boasts capabilities such as completing a whole genome process in 25 minutes at a cloud computing cost of $1, thus encouraging efficiency, cost-effectiveness, and scalability. This technological breakthrough significantly improves the speed and availability of genomic data analysis, making it particularly valuable in the whole genome and exome sequencing market by facilitating prompt decision-making and broader implementation of personalized medicine.

Get Instant Access to the Global Whole Genome And Exome Sequencing Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report

How Are Key Segments Defining the Competitive Landscape of the Whole Genome And Exome Sequencing Market?

The whole genome and exome sequencing market covered in this report is segmented –

1) By Product Type: Kits, Instruments

2) By Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)

3) By Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research, Other Applications

4) By End user: Research Center, Academic And Government Institutions, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits: Library Preparation Kits, Target Enrichment Kits, DNA Extraction Kits

2) By Instruments: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Third-Generation Sequencing Systems

Which Regions Are Significant to the Growth of the Whole Genome And Exome Sequencing Market?

North America was the largest region in the whole genome and exome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Parameters Define the Whole Genome And Exome Sequencing Market’s Scope?

Whole genome sequencing (WGS) and exome sequencing (ES) are comprehensive genetic analysis techniques that involve determining the complete DNA sequence of an organism’s genome and sequencing the protein-coding regions of the genome. These analyses are used to sequence a person’s DNA for diagnosing genetic diseases and identifying cancer mutations.

Browse Through More Similar Reports By The Business Research Company:

Next Generation Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report

DNA Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

Prenatal DNA Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/prenatal-dna-sequencing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: